Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 2, 2004, Pages 245-251

  Díaz Véliz, Gabriela ^a   Mora, Sergio ^a   Gómez, Patricia ^a   Dossi, Ma Teresa ^a   Montiel, Juan ^a   Arriagada, Christian ^a   Aboitiz, Francisco ^a   Segura Aguilar, Juan ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Dopamine; DT diaphorase; Manganese; Neurodegeneration; Parkinsonism

Indexed keywords

DICOUMAROL; MANGANESE; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME INHIBITION; EVALUATION; FOREBRAIN; LOCOMOTION; MALE; MOTOR DYSFUNCTION; NEUROTOXICITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 1642452733     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.10.016     Document Type: Article

References (27)

1. Archibald F.S., Fridovich I. The scavenging of superoxide radical by manganous complexes: in vitro. Arch. Biochem. Biophys. 214:1982;452-463.
2. Archibald F.S., Tyree C. Manganese poising and the attack of trivalent manganese upon catecholamines. Arch. Biochem. Biophys. 256:1987;638-650.
3. Arriagada C., Dagnino-Subiabre A., Caviedes P., Martin Armero J., Caviedes R., Segura-Aguilar J. Studies of aminochrome toxicity in a mouse derived neuronal cell line: is this toxicity mediated via glutamate transmission? Amino Acids. 18:2000;363-373.
4. Baez S., Linderson Y., Segura-Aguilar J. Superoxide dismutase and catalase enhance autoxidation during one-electron reduction of aminochrome by NADPH-cytochrome P-450 reductase. Biochem. Mol. Med. 54:1995;12-18.
5. Barbeau A. Manganese and extrapyramidal disorders. Neurotoxicology. 5:1984;13-36.
6. Brenneman K.A., Cattley R.C., Ali S.F., Dorman D.C. Manganese-induced developmental neurotoxicity in the CD rat: is oxidative damage a mechanism of action? Neurotoxicology. 20:1999;477-487.
7. Díaz-Véliz G., Mora S., Dossi M.T., Gómez P., Arriagada C., Montiel J., et al. Behavioral effects of aminochrome and dopachrome injected in the rat substantia nigra. Pharmacol. Biochem. Behav. 73:2002;843-850.
8. Dorman D.C., Struve M.F., Vitarella D., Byerly F.L., Goetz J., Miller R. Neurotoxicity of manganese chloride in neonatal and adult CD rats following subchronic (21-days) high-dose oral exposure. J. Appl. Toxicol. 20:2000;179-187.
9. Dubois B., Pillon B. Cognitive deficit in Parkinson's disease. J. Neurol. 244:1997;2-8.
10. Graham D.G., Tiffany S.M., Bell W.B. Jr., Guthnecht W.F. Autooxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14:1978;644-653.
11. Kostrzewa R., Segura-Aguilar J. Neurotoxicological and neuroprotective elements in Parkinson's disease. Neurotoxicol. Res. 4:2002;83-86.
12. Kulisevsky J. Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs Aging. 16:2000;365-379.
13. Lee J.W. Manganese intoxication. Arch. Neurol. 57:2000;597-599.
14. Mora S., Díaz-Véliz G. Intracerebral administration of neuropeptides: an assessment of behavioral change. Michael Conn P. Paradigms for the study of behavior. Methods in neurosciences. vol. 14:1993;180-193 Academic Press, San Diego, CA.
15. Paris I., Dagnino-Subiabre A., Marcelain K., Bennett L.B., Caviedes P., Caviedes R.et al. Cooper neurotoxicity is dependent on dopamine-mediated uptake and one-electron reduction of aminochrome in a rat substantia nigra neuronal cell line. J. Neurochem. 77:2001;519-529.
16. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd ed. 1986;Academic Press, San Diego, CA.
17. Schneider J.S., Pope-Coleman A. Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey. Neurodegeneration. 4:1995;245-255.
18. Schultzberg M., Segura-Aguilar J., Lind C. Distribution of DT-diaphorase in the rat brain: biochemical and immunohistochemical studies. Neuroscience. 27:1988;763-776.
19. 3+- induced neurotoxicity of dopamine prevention of quinone-derived oxygen toxicity by DT-diaphorase and superoxide dismutase. Chem. Biol. Interact. 72:1989;309-324.
20. Segura-Aguilar J., Metodiewa D., Welch C.J. Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects. Biochim. Biophys. Acta. 1381:1998;1-6.
21. Segura-Aguilar J., Metodiewa D., Baez S. The possible role of one-electron reduction of aminochrome in the neurodegenerative process of the dopamine system. Neurotoxicol. Res. 3:2001;157-166.
22. 3+ to produce a 6-OH-dopamine like rotational behaviour. Neurotoxicity Res. 4:2002;127-131.
23. Shen X.M., Dryhurst G. Iron- and manganese-catalyzed autoxidation of dopamine in the presence of L-cysteine: possible insights into iron- and manganese-mediated dopaminergic neurotoxicity. Chem. Res. Toxicol. 11:1998;824-837.
24. Smythies J. The biochemical basis of Parkinson's disease: the role of catecholamine o-quinones: a review-discussion. Neurotoxicol. Res. 4:2002;77-81.
25. Stokes A.H., Hastings T.G., Vrana K.E. Cytotoxic and genotoxic potential of dopamine. J. Neurosci. Res. 55:1999;659-665.
26. Ungerstedt U., Ljunggberg T., Sterg G. Behavioral, physiological and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurone. Adv. Neurol. 5:1974;421-426.
27. Winkler C., Kirik D., Bjorklund A., Censi M.A. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol. Dis. 10:2002;165-186.